User Posts: Kevin Doe

Roots Analysis has done a detailed study on Medical Device CROs for Regulatory Affairs Management Market, 2019-2030, covering key aspects of the industry’s ...

To order this detailed 550+ page report, please visit this link   Key Inclusions   A detailed review of the current market landscape of ...

Roots Analysis has done a detailed study on Neoantigen Targeted Therapies, 2019-2030, covering key aspects of the industry’s evolution and identifying ...

To order this detailed 320+ page report, please visit this link   Key Inclusions A detailed assessment of the current market landscape, ...

The use of neoantigens in therapy has demonstrated the ability to elicit a strong T cell mediated immune response. Several therapy candidates are being ...

More than 130 medical devices were approved by the FDA since January 2018, while several are currently being evaluated across more than 9,500 (active) clinical ...

Advances in bioinformatics and genomic data analysis have enabled the identification of cancer antigens that are generally overlooked during immune ...

Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including ...

Advances in molecular screening technology have enabled the identification of novel synthetic lethal gene combinations, enabling the development of lead ...

User Deals: Kevin Doe
Sorry. Author have no deals yet
Browsing All Comments By: Kevin Doe
Press Release Pedia
Logo
Shopping cart